This will count as one of your downloads.
You will have access to both the presentation and article (if available).
We trained and evaluated a previously in-house developed AI/ML model for COVID severity prediction using two COVID-19-positive consecutive adult patient cohorts from a single institution. The first cohort was from the time that the Delta strain was dominant accounting for <95% of cases (June 24-December 11, 2021, 820 patients, 1331 chest radiographs (CXRs)) and the second cohort was from the time that the Omicron variant was dominant (Jan 1-21, 2022, 656 patients, 970 CXRs). Inclusion criteria were COVID-positivity and the availability of CXR imaging exams, in general for patients not admitted to ICU and prior to ICU admission for those patients admitted to ICU as part of their treatment. Exclusion criteria were image acquisition in ICU or the presence of mechanical ventilation. Our image-based AI/ML model was trained to predict, based on each frontal CXR from a COVID-positive patient, whether this patient would be admitted to ICU within a 24, 48, 72, or 96-hour window. The model was evaluated 1) in a cross-sectional test when trained on a subset/tested on an independent subset of the Delta cohort, 2) similarly for the Omicron cohort, and 3) in a longitudinal test when trained on the Delta cohort/tested on the Omicron cohort.
Cohorts were similar in ICU admission rate and fraction of portable CXRs, while immunization rate was higher for the Omicron cohort. The model did not demonstrate signs of aging with performances in the longitudinal test being very similar to those within the Delta cohort, e.g., an area under the ROC curve in the task of predicting ICU admission within 24 hours of 0.76 [0.68; 0.84] when trained/tested within the Delta cohort and 0.77 [0.73; 0.80] for the longitudinal test (p>0.05). The performance within the Omicron cohort was similar as well, at 0.76 [0.66; 0.84].
Our AI/ML model for COVID-severity prediction did not demonstrate signs of aging in a longitudinal test when trained on the Delta cohort and applied as-is to the Omicron cohort.
This will count as one of your downloads.
You will have access to both the presentation and article (if available).
View contact details
No SPIE Account? Create one